# FDA Inspection 1278383 - Avista Pharma Solutions, Inc. dba Cambrex - July 25, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/49901d52-564d-4e1c-a292-69b90143b94a/
Source feed: FDA_Inspections

> FDA Inspection 1278383 for Avista Pharma Solutions, Inc. dba Cambrex on July 25, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1278383
- Company Name: Avista Pharma Solutions, Inc. dba Cambrex
- Inspection Date: 2025-07-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1113974 - 2019-12-18](https://www.globalkeysolutions.net/api/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/43a50e53-b23a-4132-b1c6-e57509860e23/)
- [FDA Inspection 1067530 - 2018-09-05](https://www.globalkeysolutions.net/api/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/d175dd6d-7561-482d-b246-920920a41ec5/)
- [FDA Inspection 988732 - 2016-06-15](https://www.globalkeysolutions.net/api/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/c88cfac6-d9aa-4a5a-adc0-be20464a8181/)
- [FDA Inspection 850250 - 2013-09-27](https://www.globalkeysolutions.net/api/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/51fdbe29-4c8a-4db0-b664-5ef7edf67340/)
- [FDA Inspection 696758 - 2010-10-27](https://www.globalkeysolutions.net/api/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/d67de3ad-526d-40d3-99fd-0b58abf42d77/)

Company: https://www.globalkeysolutions.net/companies/avista-pharma-solutions-inc-dba-cambrex/abe58c04-c144-4601-a4df-a290928bafa5

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c